SUBSTIPHARM
Cédric Ripert is an experienced professional who has held various leadership roles in companies such as SUBSTIPHARM, Recordati S.p.A., and Shire. With a background in market research, sales force effectiveness, and strategic planning, Cédric has also been involved in business development, licensing, and distributor management. Currently serving as Chief Commercial Officer at SUBSTIPHARM, Cédric has a strong track record of leading international business units and managing cross-functional teams. Cédric's educational background includes a Master's Degree in International Project Management from ESCP Business School.
SUBSTIPHARM
Substipharm is a privately held pharmaceutical Group. We develop, supply and commercialize pharmaceuticals in more than 60 countries worldwide. Our portfolio of products that we currently license out or distribute directly or through partners comprises more than 60 different molecules. Our development pipeline includes as well more than 40 ongoing projects. We have a successful portfolio of pharmaceutical products and vaccines including: Mature brands Generics Over the counter (OTC) pharmaceuticals Difficult to develop medicines Value added presentations Biological products including vaccines: